[Cu(NN)]ClO, a Copper (I) Complex as an Antimicrobial Agent for the Treatment of Piscirickettsiosis in Atlantic Salmon.

Int J Mol Sci

Laboratory of Natural Products Chemistry, Centre of Aquatic Biotechnology, Faculty of Chemistry and Biology, University of Santiago of Chile, Santiago 9160000, Chile.

Published: March 2024

is the pathogen that most affects the salmon industry in Chile. Large quantities of antibiotics have been used to control it. In search of alternatives, we have developed [Cu(NN)]ClO where NN = 6-((quinolin-2-ylmethylene)amino)-2H-chromen-2-one. The antibacterial capacity of [Cu(NN)]ClO was determined. Subsequently, the effect of the administration of [Cu(NN)]ClO on the growth of , modulation of the immune system and the intestinal microbiota was studied. Finally, the ability to protect against a challenge with was evaluated. The results obtained showed that the compound has an MIC between 15 and 33.9 μg/mL in four isolates. On the other hand, the compound did not affect the growth of the fish; however, an increase in the transcript levels of IFN-γ, IL-12, IL-1β, CD4, lysozyme and perforin was observed in fish treated with 40 μg/g of fish. Furthermore, modulation of the intestinal microbiota was observed, increasing the genera of beneficial bacteria such as and as well as potential pathogens such as and . Finally, the treatment increased survival in fish challenged with by more than 60%. These results demonstrate that the compound is capable of protecting fish against , probably by modulating the immune system and the composition of the intestinal microbiota.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011784PMC
http://dx.doi.org/10.3390/ijms25073700DOI Listing

Publication Analysis

Top Keywords

intestinal microbiota
12
immune system
8
fish
5
[cunn]clo
4
[cunn]clo copper
4
copper complex
4
complex antimicrobial
4
antimicrobial agent
4
agent treatment
4
treatment piscirickettsiosis
4

Similar Publications

Necrotizing enterocolitis (NEC) is a devastating disease of the neonatal gastrointestinal tract. Volatile organic compounds (VOCs), odoriferous compounds released as a byproduct of bacterial metabolism, can be used as a proxy for gut health. We hypothesized that patients with NEC would have different microbial profiles and elicit different VOC signatures as assessed by gas chromatography/mass spectrometry (GC/MS) or an electronic nose compared to controls.

View Article and Find Full Text PDF

Treatment with antibiotics is a major risk factor for infection, likely due to depletion of the gastrointestinal microbiota. Two microbiota-mediated mechanisms thought to limit colonization include the conversion of conjugated primary bile salts into secondary bile salts toxic to growth and competition between the microbiota and for limiting nutrients. Using a continuous flow model that simulates the nutrient conditions of the distal colon, we investigated how treatment with 6 clinically used antibiotics influenced susceptibility to infection in 12 different microbial communities cultivated from healthy individuals.

View Article and Find Full Text PDF

is a major cause of nosocomial diarrhea. As current antibiotic treatment failures and recurrence of infections are highly frequent, alternative strategies are needed for the treatment of this disease. This study explores the use of bacteriocins, specifically lacticin 3147 and pediocin PA-1, which have reported inhibitory activity against .

View Article and Find Full Text PDF

Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy.

World J Diabetes

January 2025

College of Materials and Chemical Engineering, Southwest Forestry University, Kunming 650224, Yunnan Province, China.

The onset and progression of type 2 diabetes mellitus (T2DM) are strongly associated with imbalances in gut bacteria, making the gut microbiome a new potential therapeutic focus. This commentary examines the recent publication in . The article explores the association between T2DM and gut microbiota, with a focus on the pathophysiological changes related to dysbiosis.

View Article and Find Full Text PDF

Characteristics of gut microbiota dysbiosis in patients with colorectal polyps.

World J Gastrointest Oncol

January 2025

School of Life Health Information Science and Engineering, Chongqing Post and Communications University, Chongqing 400065, China.

This editorial, inspired by a recent study published in the , covers the research findings on microbiota changes in various diseases. In recurrent colorectal polyps, the abundances of , , and increase, while those of and decrease. This dysbiosis may promote the formation and recurrence of polyps.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!